Patent Publication Number: US-2021187301-A1

Title: Implantable medical device control system and control method therefor

Description:
BACKGROUND OF THE INVENTION 
     1. Field of the Invention 
     The present invention relates to an implantable medical device, and more particularly, to an implantable medical device control system that is implanted into the body to stimulate a specific part in the body and a method of controlling the same. 
     2. Description of the Related Art 
     In recent years, there have been developed an artificial organ for alleviating or treating symptoms of various diseases such as a pacemaker or the like, or various implantable medical devices such as cochlear implants, gastric stimulators, spinal cord stimulators, cardiac defibrillators, pacemakers, insulin pumps, foot drop implants, deep brain stimulation (DBS), and the like 
     Among them, the deep brain stimulation device is an implantable medical device that relieves symptoms of brain disease by applying electrical stimulation to a specific part of the brain or nerves. 
     A deep brain stimulation device according to the related art includes an electrode implanted in the brain, a control device implanted in the chest to generate an electrical stimulation signal, and a connection line for connecting the electrode and the control device. 
     The control device includes a complex electronic circuit based on a microprocessor, a battery for driving for about 5 years, an RF transceiver for communication with an outside, etc., and uses the basic structure of a cardiac pacemaker itself which is contained in a titanium case specially manufactured for stable operation for a long period in a living body and sealed by laser welding. 
     Therefore, in the case of the deep brain stimulation device according to the related art, the manufacturing cost of the control device is expensive and the size of the control device is increased, so that the implantation area reaches the chest. Specifically, when the battery reaches the end of its life within 5 years, the control device has to be replaced with a new control device through surgery. 
     In order to solve the problems, there has been disclosed a deep brain stimulation device technology to which a wireless power transmission technology is applied in following patent document 1 and patent document 2. 
     In patent document 1, there has been disclosed a deep brain stimulation device where a rotating magnetic field is formed by a rotating magnetic field disk provided inside a hat worn by a patient, and induced power is generated by an induction coil plate fixed to the lower part of the patient&#39;s scalp to be combined with the formed rotating magnetic field, thereby driving the electrode implanted in the patient brain. Thus, it is possible to correct the abnormal movement and sensing function by using power supplied wirelessly from an outside of the body. 
     In patent document 2, there has been disclosed a ultra-compact deep brain stimulation system which includes an internal device implanted on the scalp, an external device for supplying power to the internal device in a wireless power transmission scheme, where a wireless power transmitter of the external device includes an external coil in which a magnetic field is induced by power supplied from a battery and an external magnet wound around the external coil, and a wireless power receiver of the internal device includes an inner coil that is aligned with the outer coil so that AC power is formed by a magnetic field induced in the outer coil, and, an inner magnet wound by an inner coil. Since the external magnet is attached to the internal magnet, the external coil and the internal coil are aligned and the external device is combined with the internal device, thereby combining the wireless power transmission function and eliminating the need for reoperation due to battery consumption. 
     Document of Related Art 
     Patent Document 
     (Patent document 1) Korean Registered Patent No. 10-0877228 (published on Dec. 26, 2008) 
     (Patent document 2) Korean Registered Patent No. 10-1662594 (Published on Oct. 6, 2016) 
     SUMMARY OF THE INVENTION 
     A deep brain stimulation device to which the wireless power transmission technology according to the related art including patent documents 1 and 2 is applied generates induction power in a magnetic induction scheme between the rotating magnetic field disk and the induction coil plate provided in the external device and the internal device, and transmits the power to the internal device. 
     As a technology for wirelessly transmitting power into the human body, various schemes have been attempted to date, and largely, there are an electromagnetic induction scheme using electromagnetic waves, an electromagnetic resonance scheme, an electromagnetic wave scheme, an RF scheme using a radio frequency, and an ultrasonic scheme using ultrasonic waves. 
     The power transmission device using electromagnetic induction includes a charging module that generates charging power using an external power source, and a power receiving module that receives charging power through an electromagnetic induction phenomenon from the charging module. The technology is the closest technology to commercialization due to high efficiency. 
     However, as the transfer energy of electromagnetic waves rapidly decrease in inverse proportion to the square of the distance in the air, the power transmission device using electromagnetic induction is limited to the use of the charging module and the power receiving module within a few centimeters from each other. 
     For this reason, in the deep brain stimulation device to which the wireless power transmission technology using the electromagnetic induction scheme according to the related art, regardless of the load fluctuations in the internal device, as the external device continuously transmits power, the power of the battery provided in the external device is consumed, so that the power efficiency is reduced. 
     In addition, when a power receiver of an electromagnetic wave type embedded in the human body is applied, the power receiver acts as an antenna for a specific frequency band, and malfunctions due to electromagnetic interface (EMI) interference occur when external electromagnetic wave noise using the frequency of the corresponding band is present. 
     In addition, in the electromagnetic wave scheme, when the transmitter generates electromagnetic waves, the receiver receives the electromagnetic waves by using a plurality of rectennas in which an antenna and a rectifier are combined with each other and converts them into power, so that power can be transmitted over a long distance, but the yield is low and the electromagnetic wave itself is harmful to the human body. 
     In addition, the power transmission device using the radio frequency collects energy of RF having a very long propagation distance, and supplies power to an electronic device or a sensor. RF exists in the air, and its propagation distance is very wide. However, RF has a low energy density itself or a low energy amount after energy conversion is low. 
     The ultrasonic wireless power transmission scheme uses a piezoelectric effect of a ferroelectric material. 
     That is, when a compressive force or tensile force, which is a mechanical external force, is applied to both ends of a piezoelectric body, electricity is generated, and on the contrary, when an electric field is applied, the displacement of contraction or relaxation is generated. When the latter is used, ultrasonic waves may be generated, and when the former is used, electricity may be generated by the generated ultrasonic pressure. 
     Therefore, the ultrasonic wireless power transmission scheme uses such piezoelectric phenomenon to generate ultrasonic waves from the outside and transmit them to the inside of the human body, and then an ultrasonic receiver including an internal piezoelectric body converts acoustic energy (ultrasonic waves) into electrical energy to transmit power. Since ultrasonic waves are sound waves, unlike light, a medium is required to propagate, and the transmission speed varies depending on the characteristics of the medium layer. 
     Since 70% of human tissue is water, the transmission rate of ultrasonic waves in the body has a value similar to that in water. 
     For this reason, ultrasonic waves have been proven to be safe in the medical field and have been applied to patient diagnosis and medical devices. 
     When acoustic vibration generated from an ultrasonic device vibrates the transmission matching layer with the medium, and piezoelectric mechanical energy is transmitted to the receiving device through the matching layer that receives vibration, such ultrasonic waves may be used as wireless power. 
     A power transmission device using ultrasonic waves having the above characteristics includes a transmitting device that generates ultrasonic waves and a receiving device that receives the generated ultrasonic waves. 
     The power transmission device using ultrasonic waves may be used in various media such as underwater or human skin. However, when the transmitting device and the receiving device are separated from each other by a medium such as water or human skin, power transmission efficiency between the ultrasonic transmitting and receiving devices is reduced. 
     Therefore, there is a demand for the development of a technology capable of wirelessly supplying power to an internal device using ultrasonic waves and preventing a decrease in power transmission efficiency. 
     Meanwhile, a deep brain stimulation device according to the related art is manufactured to stimulate the brain and nerves according to a program preset by a doctor or manufacturer. 
     Therefore, the deep brain stimulation device according to the related art has limitations in appropriately treating according to various symptoms and progression levels for each patient, depending on the experience of a doctor or manufacturer. 
     For this reason, there is a demand for the development of a technology that can alleviate the symptoms caused by the disease and maximize the treatment effect by appropriately adjusting the drugs and the intensity of stimulation according to the actual symptoms or progression of a patient having a disease. 
     To solve the problems described above, an object of the present invention is to provide an implantable medical device control system capable of wirelessly transmitting power to an internal device implanted in the body using ultrasound outside the body, and a method of controlling the same. 
     Another object of the present invention is to provide an implantable medical device control system which is capable of assigning priority to various parameters for determining symptoms and progression of a patient with a disease, and adjusting the dose and administration cycle of a drug, and stimulation applied to a specific part of the body To provide a system according to the assigned priority, and a method of controlling the same. 
     Still another object of the present invention is to provide an implantable medical device control system which is capable of alleviating the symptoms of diseases and maximizing the treatment effect by controlling the intensity and cycle of stimulating a specific part of the body based on drug dose information, and a method of controlling the same. 
     Still another object of the present invention is to provide an implantable medical device control system which is capable of analyzing various parameters for determining symptoms and progression of a patient with a disease, and adjusting stimulation applied to a specific part of the body by reflecting the analysis result in real time, and a method of controlling the same. 
     Still another object of the present invention is to provide an implantable medical device control system which is capable of improving the therapeutic effect by adjusting stimulation applied to a specific part of the body in connection with information of another patient with the same disease as the patient, and a method of controlling the same. 
     Still another object of the present invention is to provide an implantable medical device control system which is capable of controlling the driving of a medical device by using internal information collected using medical devices implanted in the body and external information collected outside the body, and a method of controlling the same. 
     To achieve the objects, according to one aspect of the present invention, there is provided an implantable medical device control system that includes an implantable medical device implanted into a body to stimulate a specific area in the body; a management terminal configured to control driving of the implantable medical device by communicating with the implantable medical device through a wireless communication scheme; and a management server connected to the management terminal to communicate with the management terminal, and configured to assign priority to each parameter included in patient condition information, store and manage the priority, and provide stored information, wherein the management terminal controls the implantable medical device to adjust stimulation applied to the specific area in the body by the implantable medical device to satisfy a reference value preset for all parameters based on the assigned priority. 
     According to another aspect of the present invention, there is provided a method of controlling an implantable medical device control system, which includes (a) stimulating, by an implantable medical device, a specific area in a body by using power transmitted from an outside of the body in a wireless power transmission. scheme; (b) assigning, by a management server, priority to each parameter included in patient condition information, and storing and managing the priority; and (c) controlling, by a management terminal, the implantable medical device to adjust the stimulation applied to the specific area in the body by the implantable medical device based on the assigned priority to satisfy a reference value preset for all parameters. 
     According to still another aspect of the present invention, there is provided an implantable medical device control system which includes an implantable medical device implanted into a body to stimulate a specific area in the body; a management terminal configured to control driving of the implantable medical device by communicating with the implantable medical device through a wireless communication scheme; and a management server that is connected to the management terminal to communicate with the management terminal, analyzes condition information of a patient corresponding to each parameter for treating a disease of the patient, and provides analyzed information to the management terminal, wherein the management server analyzes all parameters included in the patient condition information, and changes a scheme of controlling the stimulation applied to the specific area in the body based on an analysis result. 
     According to still another aspect of the present invention, there is provided a method of controlling an implantable medical device control system, which includes (a) stimulating, by an implantable medical device, a specific ea in a body by using power transmitted from an outside of the body in a wireless power transmission scheme; (b) analyzing, by a management server, condition information of a patient corresponding to each parameter for treating a disease of the patient; and (c) controlling, by a management terminal, the implantable medical device to adjust the stimulation applied to the specific area in the body by the implantable medical device based on an analysis result of the management server, wherein the management server analyzes all parameters included in the patient condition information, and changes a scheme of controlling the stimulation applied to the specific area in the body based on an analysis result. 
     According to still another aspect of the present invention, there is provided an implantable medical device control system which includes an implantable medical device implanted into a body to stimulate a specific area in the body; a management terminal configured to control driving of the implantable medical device by communicating with the implantable medical device through a wireless communication scheme; and a management server that is connected to the management terminal to communicate with the management terminal, analyzes condition information of a patient corresponding to each parameter for treating a disease of the patient, and provides analyzed information to the management terminal, wherein the management server analyzes all parameters included in the patient condition information in association with information on other patients having a same disease, and changes a scheme of controlling the stimulation applied to the specific area in the body based on an analysis result. 
     According to still another aspect of the present invention, there is provided a method of controlling an implantable medical device control system, which includes (a) stimulating, by an implantable medical device, a specific area in a body by using power transmitted from an outside of the body in a wireless power transmission scheme; (b) analyzing, by a management server, condition information of a patient corresponding to each parameter for treating a disease of the patient in association with information on other patients having a same disease; and (c) controlling, by a management terminal, the implantable medical device to adjust the stimulation applied to the specific area in the body by the implemented medical device based on an analysis result of the management server, wherein the management server analyzes all parameters included in the patient condition information and the information on the other patients, and changes a scheme of controlling the stimulation applied to the specific area in the body based on an analysis result. 
     As described above, according to the implantable medical device control system and a method of controlling the same of the present invention, by assigning priority to each parameter included in the patient state information, and adjusting stimulation applied to the brain and nerves according to the assigned priority, all parameters may be allowed to satisfy the preset reference value, so that it is possible to control to keep the patient in a stable state. 
     Thus, according to the present invention, it is possible to alleviate pain or symptoms caused by a disease and maximize the treatment effect. 
     In addition, according to the present invention, by adjusting stimulation in real time according to the patient condition information, it is possible to increase the patient&#39;s satisfaction by increasing the time to maintain the stable state of the patient. 
     In addition, according to the present invention, by changing the priority of each parameter according to the degree of progression of the disease, change in symptoms, request of the patient, etc., it is possible to alleviate symptoms caused by the disease, improve the treatment effect, and keep the patient in a stable state. 
     In addition, according to the present invention, it is possible to perform a basic test on the patient condition by using vital sign information including blood pressure, body temperature, and heart rate in the patient condition information, and adjust stimulation according to the test result. 
     In addition, according to the present invention, it is possible to adjust the stimulation applied to a specific part of the body in real time by analyzing the patient condition information, disease information, and treatment information and selecting an optimal stimulation control scheme. 
     In addition, according to the present invention, it is possible to alleviate the symptoms caused by the disease, improve the treatment effect, and keep the patient in a stable state by adjusting the stimulation in real time based on the patient condition information. 
     In addition, according to the present invention, it is possible to improve patient satisfaction by adjusting the stimulation in real time based on the patient condition information and increasing the time to maintain the stabilization state of the EEG. 
     In addition, according to the present invention, by adjusting the stimulation applied to a specific part of the body in connection with the drug dose information, the dose of the drug can be reduced to prevent overshoot due to an overdose of the drug. 
     In addition, according to the present invention, by controlling stimulation in connection with drug dose information, even if the dose of the drug is reduced, the time to maintain the patient in a stable state can be increased, thereby improving patient satisfaction. 
    
    
     
       BRIEF DESCRIPTION OF THE DRAWINGS 
         FIG. 1  is a block diagram illustrating a deep brain stimulation device control system according to a first embodiment of the present invention. 
         FIG. 2  is an exploded view of the deep brain stimulation device shown in  FIG. 1 . 
         FIG. 3  is a flowchart illustrating step-by-step a method of controlling the deep brain stimulation device control system according to the first embodiment of the present invention. 
         FIG. 4  is a flowchart illustrating step by step a method of controlling a system for controlling a deep brain stimulation device according to a second embodiment of the present invention. 
         FIG. 5  is a flowchart illustrating step by step a method of controlling a system for controlling a deep brain stimulation device according to the third embodiment of the present invention. 
     
    
    
     DETAILED DESCRIPTION OF THE INVENTION 
     Hereinafter, an implantable medical device control system and a method of controlling the same according to a preferred embodiment of the present invention will be described in detail with reference to the accompanying drawings. 
     Embodiment 1 
     The present embodiment will be described using a deep brain stimulation device among implantable medical devices, but the present invention is not limited thereto. 
     That is, it should be noted that the present invention may be applied to an artificial organ such as a pacemaker or the like which is implanted into the body and used to alleviate or treat symptoms of various diseases by stimulating a specific area in the body, or various implantable medical device control systems such as cochlear implants, gastric stimulators, spinal cord stimulators, cardiac defibrillators, pacemakers, insulin pumps, foot drop implants, and the like. 
     In addition, the present embodiment is described in which power is supplied to a deep brain stimulation device by wirelessly transmitting power in an ultrasonic wireless charging scheme, but the present invention may be modified to supply power in an electromagnetic wave scheme or a radio frequency scheme as well as the ultrasonic wireless charging scheme. 
       FIG. 1  is a block diagram illustrating a deep brain stimulation device control system according to a first embodiment of the present invention. 
     A deep brain stimulation device control system according to a preferable embodiment of the present invention includes a deep brain stimulation device  10  implanted inside a scalp to stimulate a brain and a nerve, a power transmitter  20  that transmits power from an outside of the body to the deep brain stimulation device  10  in a wireless power transmission scheme using ultrasonic waves, a management terminal  30  that controls the driving of the deep brain stimulation device  10 , a management server  40  that is connected the management terminal  30  to communicate with the management terminal  30 , stores and manages patient condition information and provides the stored information, and a patient terminal  50  that receives drug information prescribed for a patient through communication with the management terminal  30 , and transmits drug dose information and detection information obtained by detecting patient condition to the deep brain stimulation device  10  and the management server  40 . 
     The power transmitter  20  may be provided as an ultrasonic transducer that receives commercial power, converts electrical energy into an ultrasonic signal having a preset frequency, and transmits the converted ultrasonic signal to the deep brain stimulation device  10 . 
     To this end, the power transmitter  20  may include a driving control unit that converts electrical energy into an ultrasonic signal to generate an ultrasonic signal, and controls to transmit the generated ultrasonic signal. 
     The power transmitter  20  may be provided with a matching layer for matching in acoustic impedance with a power receiving unit  11  of the deep brain stimulation device  10  to be described below. 
     Through communication with deep brain stimulation device  10 , the management terminal  30  receives operation state information of the deep brain stimulation device  10  and information detected by the deep brain stimulation device  10 , transmits control commands for operating the deep brain stimulation device  10 , and changes or updates a program of the deep brain stimulation device  10 . 
     To this end, the management terminal  30  may include a communication unit (not shown) to enable communication with the management server  40  and wireless communication with the deep brain stimulation device  10 . 
     Such a management terminal  30  may be provided as a doctor terminal through which a doctor checks various information about a prescribed drug or a patient condition in a hospital, prescribes a drug for a patient, and controls the stimulation by the deep brain stimulation device  10 . 
     In addition, the management terminal  30  and the management server  40  are connected to various test equipment  31  to communicate with various test equipment  31  for checking the patient condition such as blood pressure, body temperature, electromyography, electrocardiogram, and electroencephalogram of the patient, and receive test results of each test equipment  31  in real time. 
     Accordingly, the management terminal  30  may receive the analysis information analyzed by the management server  40 , and change, modify, and update a driving program that drives the deep brain stimulation device  10  according to the received analysis information. 
     In addition, the management terminal  30  may control the driving of the power transmitter  20  in the process of transmitting power in a wireless power transmission scheme. 
     The management server  40  is communicatively connected to the management terminal  30 , each examination equipment  31 , and the patient terminal  50  through a local area network or a mobile communication network. 
     Thus, the management server  40  may control to classify each parameter included in the patient condition information received from the management terminal  30 , each examination equipment  31  and the patient terminal  50  into a plurality of groups, assign priority to each classified group or parameter, satisfy all parameters to a preset reference value according to the assigned priority, and maintain the patient condition in a stable state. 
     For example, Table 1 is a table of parameters related to Parkinson&#39;s disease patients. 
     
       
         
           
               
               
               
             
               
                 TABLE 1 
               
               
                   
               
               
                   
                   
                 Measurement/ 
               
               
                 Group 
                 Parameter 
                 detection scheme 
               
               
                   
               
             
            
               
                 Drug information 
                 Prescribed medication 
                 Management terminal 
               
               
                 group 
                 information, 
                 Patient terminal 
               
               
                   
                 Medication information, 
                 Patient terminal 
               
               
                   
                 Food, health food intake 
                   
               
               
                   
                 information 
                   
               
               
                 Biometric 
                 Blood pressure, body 
                 Inspection equipment, 
               
               
                 information group 
                 temperature,  
                 Detection sensor 
               
               
                   
                 heart rate, etc. 
                   
               
               
                 Symptom 
                 Symptoms such as  
                 Management terminal, 
               
               
                 information group 
                 pain and tremor 
                 Patient terminal 
               
               
                 EEG information 
                 EEG, ECG, EMG, etc. 
                 Test equipment, 
               
               
                 group 
                   
                 Detection sensor 
               
               
                 Walking 
                 Walking, turn, Gait freeze 
                 Test equipment,  
               
               
                 information group 
                 information 
                 patient terminal 
               
               
                 Environment 
                 Information on changes  
                 Test equipment,  
               
               
                 Information Group 
                 in the surrounding  
                 patient terminal 
               
               
                   
                 environment 
                   
               
               
                 Autonomic 
                 Sleep time, sleep state 
                 Test equipment, 
               
               
                 Information Group 
                   
                 Detection sensor 
               
               
                 Exercise 
                 Exercise time during  
                 Test equipment,  
               
               
                 information group 
                 daily life, Non-exercise  
                 patient terminal 
               
               
                   
                 time information 
                   
               
               
                 Other Disease 
                 Pain from other diseases, 
                 Management terminal, 
               
               
                 Information Group 
                 Symptom information 
                 patient terminal 
               
               
                   
               
            
           
         
       
     
     The patient condition information may include not only parameters related to Parkinson&#39;s disease, but also various parameters such as information on food consumed by a patient, information on exercise or sleep of a patient, and exercise information related to changes in the surrounding environment. 
     For example, as shown in Table 1, the management server  40  may classify various parameters included in the patient condition information into a plurality of groups such as a drug information group including information on drugs prescribed for a patient, drug dose information, and information on food or health food consumed by a patient, a biometric information group obtained by detecting a patient&#39;s vital signs such as blood pressure, body temperature, and heart rate, a symptom information group obtained by detecting a patient&#39;s pain, tremors, or symptoms, EEG information group including EEG obtained by measuring patient&#39;s EEG, ECG, EMG, and the like, a gait information group obtained by detecting a gait state, including a patient&#39;s gait, turn, and gait freeze information, environmental information group obtained by detecting a movement state according to changes in the surrounding environment, autonomic nervous information group obtained by detecting information on an autonomic nervous system such as sleep time, sleep state, and the like, an exercise information group including information on exercise time during daily life and non-exercise time due to illness, and the other disease information group including other disease information including underlying diseases of a patient such as blood pressure, diabetes, and the like, and other irregular diseases such as colds or headache, and the like. 
     As an example, the gait information group may include gait information obtained by detecting a gait state including a gait cycle and a stride length of a patient in his daily life, turn information obtained by detecting a turning state when walking, and gait freeze information obtained by detecting a gait freeze state when a specific situation including a change in a width of a road or an alley during walking, and the like occurs. 
     In addition, the management server  40  may assign a priority to each classified group, analyze and digitize the test or detection information for each parameter, and provide analysis information obtained by analyzing each of digitized information according to the priority assigned to maintain the patient in a stable state to the management terminal  30  and the patient terminal  50 . 
     For example, the management server  40  may store and manage information on drugs administered to a patient, dose information, relative drug price information for each drug, prescription information including timing, period and dose of drugs prescribed for a patient, information on interaction between a drug prescribed for a patient and other drugs other than the corresponding drug, and information on interaction between prescribed drugs and food or health functional food, and may provide the stored information to the management terminal  30  and the patient terminal  50 . 
     The drug information may include the name of each drug prescribed for the patient, the time and period of administration of each drug, the daily dose and the dosage per dose. The drug dose information may be information that the patient actually takes a drug, and the user may check whether the corresponding drug is taken by touching the screen of the patient terminal  50  for each information included in the drug information. 
     In addition, the management server  40  may update each drug and related information in real time through communication with a drug information management server (not shown) managed by a government agency such as Ministry of Food and Drug Safety. 
     Accordingly, the management server  40  may manage a dose of a drug, that is, a dopamine formulation, such as a levodopa dose, prescribed for a patient to treat Parkinson&#39;s disease. 
     In addition, the management server  40  may guide a method of taking each drug or prevent prescriptions based on information on interaction between drugs prescribed for treat other diseases of a patient, such as underlying diseases such as diabetes or high blood pressure, or unusual diseases such as cold or abdominal pain. 
     In addition, the management server  40  may divide and guide the recommended food or health functional food and the prohibited food or the health functional food based on the information on the interaction between the prescribed drug and the food or the health functional food. 
     Accordingly, a doctor may check the change of each parameter included in the patient condition information, for example, a change in the degree of a disease or whether other diseases have occurred, and the management terminal  30  may change the priorities assigned through communication with the management server  40  according to the operation of the doctor. 
     In addition, the management terminal  30  may change the priority of each parameter according to the priority requested by the patient, such as relief of pain or symptoms. Meanwhile, in the present embodiment, the management server  40  assigns a basic priority, controls stimulation applied to the brain and nerves according to the priority assigned by the management terminal  30 , and controls to change the priority, but the present invention is not necessarily limited thereto. 
     That is, the present invention may be modified to change the priority assigned to each parameter by the mobile terminal  50  and to control brain and nerve stimulation according to the assigned priority. 
     In addition, the present invention may be modified such that the deep brain stimulation device  50  itself adjusts brain and nerve stimulation according to the priority assigned by the management terminal  30 . 
     However, in order to prevent the risk of an accident that may occur when the patient directly controls the driving of the deep brain stimulation device  10  by using the patient terminal  50 , preferably, the present invention is configured to change and transmit the priority to the deep brain stimulation device  10  only when a patient requests a priority change using the patient terminal  50  and it is approved through a doctor&#39;s review process through the management server  40 . 
     The patient terminal  50  transmits detection information for some of the parameters included in the patient&#39;s state information to the management server  40 , and according to the analysis information received from the management server  40 , controls the driving of the deep brain stimulation device  10 . 
     That is, the patient terminal  50  may receive information on a drug prescribed for the patient from the management server  40 , receive information on taking the drug from the user (hereinafter, referred to as ‘patient’) including the patient or guardian, and transmit the information to the deep brain stimulation device  10 . 
     In addition, the patient terminal  50  may receive information on the drug taken by the patient to treat diseases other than Parkinson&#39;s disease and food or health functional food information, and transmit the information to the management server  40  and the deep brain stimulation device  10 . 
     To this end, a dedicated application for receiving the patient condition information and controlling the driving of the deep brain stimulation device  10  may be installed in the patient terminal  50  which is provided with various terminals having a wireless communication function, such as a smart phone, a tablet PC, a laptop computer, and the like, which can access to a mobile communication network or a local area network. 
     In addition, a communication module (not shown) may be provided in the patient terminal  50  to enable communication with the deep brain stimulation device  10  using a short-range wireless communication technology such as Bluetooth. 
     In addition, the patient terminal  50  may be communicatively connected to a smart device (not shown) having a detecting function such as a smart watch having a function of directly detecting the patient&#39;s blood pressure, body temperature, and heart rate, a smart band for detecting the EEG of a patient, etc. 
     In addition, the patient terminal  50  may be provided with a GPS module for generating movement information of the patient and a detection sensor  51  such as a 3-axis gyro sensor. 
     Next, the configuration of the deep brain stimulation device will be described in detail with reference to  FIGS. 1 and 2 . 
       FIG. 2  is an exploded view of the deep brain stimulation device shown in  FIG. 1 . 
     As shown in  FIGS. 1 and 2 , the deep brain stimulation device  10  includes a power receiving unit  11  for receiving power transmitted from the power transmitter  20 , a battery  12  charged with the power received through the power receiving unit  11 , and a stimulation unit  13  for stimulating a brain and a nerve by using the power supplied from the battery  12 . 
     In addition, the deep brain stimulation device  10  may further include a control unit  14  that controls driving of each device provided in the deep brain stimulation device  10 , and a communication unit  15  that communicates with the management terminal  30  and the patient terminal  50  in a wireless communication scheme  15 . 
     The power receiving unit  11  may be provided as an ultrasonic transducer that receives power by converting the ultrasonic signal transmitted from the power transmitter  20  into electrical energy. 
     To this end, the power receiving unit  11  may include a plurality of piezoelectric devices that change the pressure by an ultrasonic signal into a voltage of electrical energy. 
     The piezoelectric device may be manufactured by using zirconate (PbZrO 3 ) which is a ceramic material having piezoelectricity and pyroelectricity, and lead zirconate titanate (PZT) which is a solid solution of titanate (PbTiO 3 ). 
     As shown in  FIG. 2 , the power receiving unit  11 , the control unit  14 , the communication unit  15 , and the battery  12  may be sequentially stacked in the case  80  in a vertical direction, and a matching layer  16  for packaging an upper surface of the case  17  and matching acoustic impedance with the power transmitter  20  may be provided on an upper side of the power receiving unit  11 . 
     That is, the ultrasonic signal transmitted from the power transmitter  20  is transmitted to the power receiving unit  11  through a medium layer such as skin or blood of the human body. 
     The transmission efficiency of power wirelessly transmitted between the power transmitter  20  and the power receiving unit  11  may be changed according to the characteristics of the medium layer, that is, the material of the medium layer, the geometry, the transmission medium, the attenuation, and the distance between the power transmitter  20  and the power receiving unit  11 . 
     Accordingly, the present invention may minimize the return loss of power transmitted to the power receiving unit  11  by using the material and geometry of the matching layer  16  provided in the power transmitter  20  and the power receiving unit  11 , respectively, thereby improving the power transmission efficiency. 
     The battery  12  may be provided as a rechargeable secondary battery. 
     The stimulation unit  13  may include an internal micro control unit (not shown) and a stimulation circuit (not shown) for generating a specific stimulation waveform for stimulating the brain and nerves by using the DC power supplied from the battery  12 , and a plurality of electrodes for stimulating the brain and nerves according to the stimulation waveform generated by the stimulation circuit. 
     In this case, each electrode may be provided with a plurality of channels for transmitting stimulation signals to the brain and nerves. 
     The internal micro control unit may change the current value, voltage value, and period of the stimulation signal that stimulates the brain and nerves according to the control signal of the control unit  14 , and change the position and combination of the electrodes that stimulate the brain and nerves among the plurality of electrodes. 
     Some or all of the electrodes may have a function of detecting an EEG of a patient changed by drugs taken by the patient and brain and nerve stimulation. 
     As described above, the detection signal obtained by detecting an EEG through the electrode is transmitted to the control unit  14 . 
     The control unit  14  may be provided as a central control unit that controls driving of each device provided in the deep brain stimulation device  10 . 
     The control unit  14  may control the driving of the stimulation unit  13  to control stimulation applied to the brain and nerves by executing a driving program stored in a memory (not shown). 
     In the process of stimulating the brain and nerves, the control unit  14  may control to transmit load information obtained by detecting the change in the power load due to various factors such as a skin thickness, a degree of hair growth, a blood flow, and the like to the management terminal  30  through the communication unit  15 . 
     In particular, the control unit  14  may generate a control signal to control stimulation applied to the brain and nerves according to the control signal received from the management terminal  30  or the patient terminal  50  and the EEG detection signal detected through each electrode. 
     Meanwhile, the deep brain stimulation device  10  may further include a sensing unit  18  capable of detecting the above-described load information, and a detection signal output from the sensing unit  18  may be transmitted to the control unit  14 . 
     In addition to the above-described load information, the sensing unit  18  may include a plurality of sensing sensors for detecting various information such as vital signs such as body temperature, blood pressure, heart rate, and respiration volume of the human body, temperature of the battery  12 , and an EEG as well as the above-described load information. 
     Therefore, the control unit  14  may control the stimulus signal to stimulate the brain and nerves in connection with the drug dose information and the EEG detection signal and the detection information detected by the sensing unit  18 . 
     In addition, the control unit  14  may control to change or update the program for driving the stimulation unit  13  according to the control signal received from the management terminal  30  through the communication unit  15 . 
     Next, a method of controlling the deep brain stimulation device control system according to the first embodiment of the present invention will be described in detail with reference to  FIG. 3 . 
       FIG. 3  is a flowchart illustrating step-by-step a method of controlling the deep brain stimulation device control system according to the first embodiment of the present invention. 
     In step S 10  of  FIG. 3 , the control unit  14  of the deep brain stimulation device  10  executes a previously stored driving program and controls the driving of the stimulation unit  13  to stimulate the brain and nerves through the plurality of electrodes. 
     When communication with the management terminal  30  (or the patient terminal  50 ) is connected through the communication unit  15  of the deep brain stimulation device  10  in step S 12 , the management terminal  30  assigns priority to all parameters by using the information from the management server  40 . 
     In step S 14 , the test equipment  31  transmits information about the patient condition such as blood pressure, body temperature, heart rate, electromyography, electrocardiogram, and electroencephalogram (EEG) of the patient to the management terminal  30 . 
     In this case, the detection sensor  51  of the patient terminal  50  and the smart device communicatively connected to the patient terminal  50  may also detect vital sign information in the patient condition information and transmit the vital sign information to the patient terminal  50 . The patient terminal  50  may transmit the received detection information and the drug dose information input from the patient to the management server  40 , the management terminal  30 , and the deep brain stimulation device  10 . 
     Then, in step S 16 , the management terminal  30  performs a basic test on the patient condition by using the vital sign information including the blood pressure, body temperature, and heart rate in the received patient condition information. 
     As a result of testing such vital sign information, when the patient is in a normal state, the management terminal  30  assigns priority to all parameters through communication with the management server  40  in step S 18 . In step S 20 , the management terminal  30  analyzes and digitizes the detection information and input information of each parameter, and transmits each of digitized information to the deep brain stimulation device  10  to keep the patient in a stable state. 
     Then, in step S 22 , the control unit  14  of the deep brain stimulation device  10  receives the analysis result from the management terminal  30 , and according to the received analysis result, controls the driving of the stimulation unit  13  to adjust the intensity and period of stimulation applied to the brain and nerves. 
     As described above, the present invention may assign priority to each parameter included in the patient state information, and adjust stimulation applied to the brain and nerves according to the assigned priority, thereby allowing all parameters to satisfy the preset reference value, so that it is possible to control to keep the patient in a stable state. 
     Meanwhile, in the process of controlling brain and nerve stimulation according to the patient condition information, in step S 24 , the control unit  14  checks whether power is received from the power transmitter  20  by using an ultrasonic wireless power transmission technology. 
     When, as a test result in step S 24 , power is received, the power receiving unit  11  of the deep brain stimulation device  10  receives the power and charges the battery  12  in step S 26 . 
     Then, the control unit  14  returns to step S 10  or step S 12  to supply the power charged in the battery  12  to each device, and controls to repeat the subsequent steps. 
     While repeatedly performing such processes, the management terminal  30  may change the priority according to the degree of progression of the disease, change of symptoms, request of the patient, etc., and adjust stimulation applied to the brain and nerves according to the changed priority. 
     Accordingly, the present invention changes the priority of each parameter according to the degree of progression of the disease, the change of symptoms, and the request of the patient, thereby alleviating the symptoms caused by the disease, improving the treatment effect, and maintaining the patient in a stable state. 
     Embodiment 2 
     A deep brain stimulation device control system according to the second embodiment of the present invention has the same configuration as that of the deep brain stimulation device control system described in the first embodiment. 
     However, in the deep brain stimulation device control system according to the second embodiment of the present invention, the management server  40  is communicatively connected to the management terminal  30 , analyzes the patient condition information corresponding to various parameters for treating the disease of the patient, and provides analysis information to the management terminal  30 . 
     The management server  40  may simulate a treatment process after changing the priority based on the patient condition information, and may approve whether to change the priority according to the simulation result. 
     Meanwhile, the management server  40  may analyze the treatment information and disease progress information as a whole after diagnosis of the patient disease, change the scheme of controlling the stimulation applied to the nerves according to the analysis result, and perform a simulation according to the changed scheme, thereby predicting the treatment effect. 
     To this end, the management server  40  may provide an optimal stimulation control scheme by using a machine learning scheme for disease information and treatment information of a patient. 
     Next, a method of controlling a system for controlling a deep brain stimulation device according to a second embodiment of the present invention will be described in detail with reference to  FIG. 4 . 
       FIG. 4  is a flowchart illustrating step by step a method of controlling a system for controlling a deep brain stimulation device according to a second embodiment of the present invention. 
     In step S 30  of  FIG. 4 , the control unit  14  of the deep brain stimulation device  10  executes a previously stored driving program and controls the driving of the stimulation unit  13  to stimulate the brain and nerves through a plurality of electrodes. 
     When communication with the management terminal  30  (or the patient terminal  50 ) is connected through the communication unit  15  of the deep brain stimulation device  10  in step S 32 , the management terminal  30  assigns priority to all parameters by using the information from the management server  40 . 
     In step S 34 , the test equipment  31  transmits information about the patient condition such as blood pressure, body temperature, heart rate, electromyography, electrocardiogram, and electroencephalogram (EEG) of the patient to the management terminal  30 . 
     In this case, the detection sensor  51  of the patient terminal  50  and the smart device communicatively connected to the patient terminal  50  may also detect vital sign information of the patient and transmit the vital sign information to the patient terminal  50 . The patient terminal  50  may transmit the received detection information and the drug dose information input from the patient to the management server  40 , the management terminal  30 , and the deep brain stimulation device  10 . 
     Then, in step S 36 , the management terminal  30  performs a basic test on the patient condition by using the vital sign information including the blood pressure, body temperature, and heart rate in the received patient condition information. 
     As a result of testing such vital sign information, in step S 38 , when the patient is in a normal state, the management terminal  30  transmits the patient condition information to the management server  40 , and the management server  40  analyzes the patient condition information in connection with the received patient condition information and the previously stored patient disease information and treatment information. 
     In step S 40 , the management server  40  changes the scheme of adjusting the stimulation applied to the nerve according to the analysis result, performs a simulation according to the changed scheme, thereby predicting the treatment effect to select the optimal stimulation adjustment scheme. 
     In step S 42 , the stimulation adjustment scheme selected through the above-described process is transmitted to the deep brain stimulation device  10  through the management terminal  30 . 
     Then, in step S 44 , the control unit  14  of the deep brain stimulation device  10  controls the driving of the stimulation unit  13  to adjust the intensity and period of stimulation applied to the brain and nerves according to the stimulation adjustment scheme received form the management terminal  30 . 
     As described above, the present invention selects the optimal stimulation adjustment scheme by analyzing the patient condition information, disease information, and treatment information, and adjusts stimulation applied to the brain and nerves, thereby allowing all parameters to satisfy the preset reference value, so that it is possible to control to keep the patient in a stable state. 
     Meanwhile, in step S 46 , in the process of controlling brain and nerve stimulation according to the patient condition information, the control unit  14  checks whether power is received from the power transmitter  20  by using an ultrasonic wireless power transmission technology. 
     When, as a test result in step S 46 , power is received, the power receiving unit  11  of the deep brain stimulation device  10  receives the power and charges the battery  12  in step S 48 . 
     Then, the control unit  14  returns to step S 30  or step S 32  to supply the power charged in the battery  12  to each device, and controls to repeat the subsequent steps. 
     While repeatedly performing such processes, the management terminal  30  continuously transmits the patient condition information to the management server  40 , and the management server  40  analyzes the received patient condition information, disease information, and treatment information to select the optimal stimulation adjustment scheme, so that it is possible to control to adjust the stimulation applied to the brain and nerves. 
     Accordingly, according to the present invention, the stimulation applied to the brain and nerves may be adjusted in real time based on the patient condition information, so that the symptoms caused by the disease may be alleviated, the treatment effect may be improved, and the patient may be maintained in a stable state. 
     Embodiment 3 
     A deep brain stimulation device control system according to the third embodiment of the present invention has the same configuration as that of the deep brain stimulation device control system described in the second embodiment. 
     However, in the deep brain stimulation device control system according to the third embodiment of the present invention, the management server  40  may be operated in connection with information of another patient having the same disease as the corresponding patient as well as the information of the corresponding patient, thereby providing an optimal stimulation adjustment scheme. 
     As described above, the present invention may further improve the treatment effect by adjusting the stimulation applied to the brain and nerves in connection with the patient&#39;s own information and the information of another patient with the same disease, and may perform treatment with a scheme verified through other patients, so that it is possible to increase the safety for treatment. 
     Next, a method of controlling a system for controlling a deep brain stimulation device according to the third embodiment of the present invention will be described in detail with reference to  FIG. 5 . 
       FIG. 5  is a flowchart illustrating step by step a method of controlling a system for controlling a deep brain stimulation device according to the third embodiment of the present invention. 
     In step S 60  of  FIG. 5 , the control unit  14  of the deep brain stimulation device  10  executes a previously stored driving program and controls the driving of the stimulation unit  13  to stimulate the brain and nerves through a plurality of electrodes. 
     When communication with the management terminal  30  (or the patient terminal  50 ) is connected through the communication unit  15  of the deep brain stimulation device  10  in step S 62 , the management terminal  30  assigns priority to all parameters by using the information from the management server  40 . 
     In step S 64 , the test equipment  31  transmits information about the patient condition such as blood pressure, body temperature, heart rate, electromyography, electrocardiogram, and electroencephalogram (EEG) of the patient to the management terminal  30 . 
     In this case, the detection sensor  51  of the patient terminal  50  and the smart device communicatively connected to the patient terminal  50  may also detect vital sign information of the patient and transmit the vital sign information to the patient terminal  50 . The patient terminal  50  may transmit the received detection information and the drug dose information input from the patient to the management server  40 , the management terminal  30 , and the deep brain stimulation device  10 . 
     Then, in step S 66 , the management terminal  30  performs a basic test on the patient condition by using the vital sign information including the blood pressure, body temperature, and heart rate in the received patient condition information. 
     As a result of testing such vital sign information, in step S 68 , when the patient is in a normal state, the management terminal  30  transmits the patient condition information to the management server  40 , and the management server  40  analyzes the patient condition information in connection with the received patient condition information, the previously stored patient disease information and treatment information, and the information of another patient with the same disease. 
     In step S 70 , the management server  40  changes the scheme of adjusting the stimulation applied to the nerve according to the analysis result, performs a simulation according to the changed scheme, thereby predicting the treatment effect to select the optimal stimulation adjustment scheme. 
     In step S 72 , the stimulation adjustment scheme selected through the above-described process is transmitted to the deep brain stimulation device  10  through the management terminal  30 . 
     Then, in step S 74 , the control unit  14  of the deep brain stimulation device  10  controls the driving of the stimulation unit  13  to adjust the intensity and period of stimulation applied to the brain and nerves according to the stimulation adjustment scheme received form the management terminal  30 . 
     As described above, the present invention selects the optimal stimulation adjustment scheme by analyzing the patient condition information, disease information, and treatment information, and adjusts stimulation applied to the brain and nerves, thereby allowing all parameters to satisfy the preset reference value, so that it is possible to control to keep the patient in a stable state. 
     Meanwhile, in step S 76 , in the process of controlling brain and nerve stimulation in connection with the condition information of the corresponding patient and the information of another patient, the control unit  14  checks whether power is received from the power transmitter  20  by using an ultrasonic wireless power transmission technology. 
     When, as a test result in step S 76 , power is received, the power receiving unit  11  of the deep brain stimulation device  10  receives the power and charges the battery  12  in step S 48 . 
     Then, the control unit  14  returns to step S 60  or step S 62  to supply the power charged in the battery  12  to each device, and controls to repeat the subsequent steps. 
     While repeatedly performing such processes, the management terminal  30  continuously transmits the patient condition information to the management server  40 , and the management server  40  analyzes the received patient condition information, disease information, and treatment information in connection with the information of another patient to select the optimal stimulation adjustment scheme, so that it is possible to control to adjust the stimulation applied to the brain and nerves. 
     Accordingly, according to the present invention, the stimulation applied to the brain and nerves may be adjusted in real time based on the patient condition information, so that the symptoms caused by the disease may be alleviated, the treatment effect may be improved, and the patient may be maintained in a stable state. 
     In addition, the present invention may further improve the treatment effect by adjusting the stimulation applied to the brain and nerves in connection with the patient&#39;s own information and the information of another patient with the same disease, and may perform treatment with a scheme verified through other patients, so that it is possible to increase the safety for treatment. 
     As described above, although the invention made by the present inventor has been described in detail with reference to the embodiments, the invention is not limited to the above embodiments, and may be variously modified without departing from the scope. 
     In the above embodiments, the configuration of a deep brain stimulation device among implantable medical devices has been described, but the present invention may be applied to an artificial organ such as a pacemaker or the like which is implanted into the body and used to alleviate or treat symptoms of various diseases by stimulating a specific area in the body, or various implantable medical device such as cochlear implants, gastric stimulators, spinal cord stimulators, cardiac defibrillators, pacemakers, insulin pumps, foot drop implants, and the like. 
     Further, in the above embodiments, it has been described that the stimulation unit and the sensing unit are provided at the same time. However, the present invention may be applicable to a medical device which is provided only with a sensing unit, such as a nerve stimulator stimulating nerves and a brain machine interface (BMI), to detect only load information or biometric information without stimulation. 
     In addition, in the above embodiment, it has been described that power is supplied to the deep brain stimulation device by transmitting power wirelessly in an ultrasonic wireless charging scheme, but the present invention may be modified to supply not only an ultrasonic wireless charging scheme, but also an electromagnetic wave scheme or a radio frequency scheme. 
     The present invention is applied to techniques of an implantable medical device control system and a method of controlling the same that transmit power to a medical device implanted in the body in a wireless power transmission scheme using ultrasonic waves.